KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Debt Ratio (2017 - 2023)

Historic Debt Ratio for Bionano Genomics (BNGO) over the last 7 years, with Q3 2023 value amounting to 0.05.

  • Bionano Genomics' Debt Ratio rose 9128.23% to 0.05 in Q3 2023 from the same period last year, while for Sep 2023 it was 0.05, marking a year-over-year increase of 9128.23%. This contributed to the annual value of 0.03 for FY2022, which is N/A changed from last year.
  • Per Bionano Genomics' latest filing, its Debt Ratio stood at 0.05 for Q3 2023, which was up 9128.23% from 0.04 recorded in Q2 2023.
  • Bionano Genomics' 5-year Debt Ratio high stood at 1.03 for Q3 2019, and its period low was 0.03 during Q2 2022.
  • Over the past 5 years, Bionano Genomics' median Debt Ratio value was 0.27 (recorded in 2020), while the average stood at 0.36.
  • Its Debt Ratio has fluctuated over the past 5 years, first skyrocketed by 24973.32% in 2019, then crashed by 9565.18% in 2021.
  • Over the past 5 years, Bionano Genomics' Debt Ratio (Quarter) stood at 0.66 in 2019, then crashed by 59.38% to 0.27 in 2020, then plummeted by 85.7% to 0.04 in 2021, then fell by 21.01% to 0.03 in 2022, then surged by 80.18% to 0.05 in 2023.
  • Its Debt Ratio was 0.05 in Q3 2023, compared to 0.04 in Q2 2023 and 0.03 in Q1 2023.